US AORTIC PRODUCT CATALOG
|
|
- Tabitha Watkins
- 6 years ago
- Views:
Transcription
1 US AORTIC PRODUCT CATALOG Endurant Aptus II/IIs Valiant Captivia Heli-FX EndoAnchor System Aptus EndoAnchor TourGuide Sentrant Reliant
2 Endurant II/IIs Endurant AUI Talent Occluder Valiant Captivia Aptus EndoAnchor Aptus TourGuide Sentrant Reliant
3 TABLE OF CONTENTS 02 Endurant II / IIs AAA Stent System 28 Talent Occluder with Occluder Delivery System 30 Valiant Thoracic Stent 44 Aptus Heli-FX EndoAnchor System 46 TourGuide Steerable Sheath Captivia Delivery System 48 Sentrant Introducer Sheath with Hydrophilic Coating 50 Reliant Stent Balloon Catheter
4 Endurant II / IIs AAA Stent System FEATURES* Endurant IIs Expands Anatomical Customization Options A three-piece system that leverages the proven design of the Endurant II abdominal stent graft Enables in-situ sizing with select ipsilateral limbs, allowing a 3-5 stent overlap for adjustment during case Allows easier pre-case planning to simplify sizing Low Profile and Easy Access Low profile and hydrophilic coating enhances access and trackability Flexible, kink-resistant delivery system facilitates stent graft delivery Complete Conformability, Optimal Seal M-shaped proximal stents provide wall apposition and minimize infolding for a short sealing zone in the infrarenal aorta Laser cut suprarenal stent anchor pins provides secure fixation to mitigate migration Spacing between limb stents optimized to conform to anatomy to reduce kinking Total Control Provides Consistent Precision Tip capture mechanism allows for precise positioning and intraoperative adjustments. Backend thumb wheel provides controlled release of the suprarenal stent and anchor pins Improved radiopacity provides increased visibility Four proximal markers assist in accurate deployment e- shaped marker assists with A/P orientation Durable Design, Dependable Performance Ultra-high molecular weight polyethylene sutures are three times stronger than surgical sutures High-density multifilament polyester graft material provides low porosity Electropolished nitinol stents improve fatigue resistance * Test data on file at Medtronic. Bench test results may not be indicative of clinical performance. Contralateral gate marker. 2
5 ENDURANT II/IIS SHORT NECK. LONG HISTORY. 3
6 Endurant II / IIs AAA Stent System PRODUCT CODE DESCRIPTION ET B F C 124 E 18 Device Configuration B - Bifurcations L - Limbs E - Iliac Extension C - Extensions & Cuffs T - Extensions & Cuffs U - Aorto-uni-iliac (AUI) Product Name ET - Endurant II ES - Endurant IIs Proximal Proximal Design F - FreeFlo W- Open Web Total Covered Length Design C - Closed Web Catheter Outer Delivery System E - Endurant II 4 ENDURANT IIs BIFURCATIONS Proximal Product Code Design Total Covered Length Delivery System Catheter Outer (F) ESBF C 103 E 18 ESBF C 103 E 18 ESBF C 103 E 18 ESBF C 103 E 20 ESBF C 103 E 20
7 ENDURANT II BIFURCATIONS Product Code Proximal Design Total Covered Length Delivery System Catheter Outer (F) ETBF C 124 E 18 ETBF C 145 E 18 ETBF C 166 E 18 ETBF C 124 E 18 ETBF C 145 E 18 ETBF C 166 E 18 ETBF C 124 E 18 ETBF C 145 E 18 ETBF C 166 E 18 ETBF C 124 E 18 ETBF C 145 E 18 ETBF C 166 E 18 ETBF C 124 E 18 ETBF C 145 E 18 ETBF C 166 E 18 ETBF C 124 E 18 ETBF C 145 E 18 ETBF C 166 E 18 ETBF C 124 E 18 ETBF C 145 E 18 ETBF C 166 E 18 ETBF C 124 E 20 ETBF C 145 E 20 ETBF C 166 E 20 ETBF C 124 E 20 ETBF C 145 E 20 ETBF C 166 E 20 ETBF C 145 E 20 ETBF C 166 E 20 ETBF C 145 E 20 ETBF C 166 E 20 5
8 Endurant II / IIs AAA Stent System LIMBS* Proximal Product Code Design Total Covered Delivery Length System Catheter Outer (F) Total Contralateral Covered Length with EII/EIIs Bifurcated Total Ipsilateral Covered Length with EIIs Bifurcated ETLW C 82 E ETLW C 93 E ETLW C 124 E ETLW C 156 E ETLW C 199 E ETLW C 82 E ETLW C 93 E ETLW C 124 E ETLW C 156 E ETLW C 199 E ETLW C 82 E ETLW C 93 E ETLW C 124 E ETLW C 156 E ETLW C 199 E ETLW C 82 E ETLW C 93 E ETLW C 124 E ETLW C 156 E ETLW C 199 E ETLW C 82 E ETLW C 93 E ETLW C 124 E ETLW C 156 E ETLW C 199 E ETLW C 82 E ETLW C 93 E ETLW C 124 E ETLW C 156 E ETLW C 199 E * The limb mates with the AUI stent graft on the ipsilateral side. These calculations assume the minimum 30 mm overlap between the bifurcated stent graft and the contralateral iliac limb per the Endurant II Stent System Instructions For Use. When using the 124 mm length bifurcated stent graft, subtract 10 mm from Total Contralateral Covered Length with Bifurcated. The 3-5 stent overlap is available only with select limbs. Please refer to the Instructions For Use for more information. 6
9 ILIAC EXTENSIONS Proximal Product Code Design Total Covered Length Delivery System Catheter Outer (F) ETEW C 82 E 14 ETEW C 82 E 14 ETEW C 82 E 16 ETEW C 82 E 16 ETEW C 82 E 18 AORTIC EXTENSIONS Proximal Product Code Design Total Covered Length Delivery System Catheter Outer (F) ETCF C 49 E 18 ETCF C 49 E 18 ETCF C 49 E 18 ETCF C 49 E 20 ETCF C 49 E 20 ETTF C 70 E 18 ETTF C 70 E 18 ETTF C 70 E 18 ETTF C 70 E 20 ETTF C 70 E 20 AUI Proximal Product Code Design Total Covered Length Delivery System Catheter Outer (F) ETUF C 102 E 18 ETUF C 102 E 18 ETUF C 102 E 18 ETUF C 102 E 20 ETUF C 102 E 20 7
10 Endurant II / IIs AAA Stent System PLACEMENT AND SIZING GUIDELINES Use the proximal radiopaque markers to position the top edge of the graft material. e-shaped MARKER ASSISTS WITH A/P ORIENTATION RADIOPAQUE MARKERS For the contralateral side: The radiopaque markers at the proximal limb should be aligned with the radiopaque markers at the flow divider of the Endurant II or Endurant IIs bifurs. For the ipsilateral side: Depending on the limb configuration used, the radiopaque markers at the proximal end of the limb should be aligned to the distal radiopaque marker on the ipsilateral leg or the flow divider marker of the Endurant IIs bifur. Select limbs will allow a 3-5 stent overlap adjustment during the case. Please refer to the Instructions for Use for more information as needed. 8
11 Each Endurant II/Endurant IIs AAA stent graft must be ordered in a size that is appropriate to fit the patient s anatomy. Proper sizing of the Endurant II/Endurant IIs AAA stent graft is the responsibility of the physician. The following suggestions for stent graft diameters are based on vessel inner wall measurements. BIFURCATIONS, AUI AND AORTIC EXTENSIONS Native Vessel Recommended Endurant II ILIAC EXTENSIONS Native Vessel Recommended Endurant II LIMBS Native Vessel Recommended Endurant II
12 Endurant II / IIs AAA Stent System COMPONENT PLACEMENT GUIDE * ENDURANT II 23, 25, 28, 32, 36 mm BIFURCATED PROXIMAL MARKERS 16 mm LIMBS PROXIMAL MARKERS BIFURCATED GRAFT 124, 145, 166 mm 12, 14 mm ALIGN MARKERS 13, 16, 20 mm LIMBS 82, 93, 124, 156, 199 mm 10, 13, 16, 20, 24, 28 mm 10
13 ENDURANT IIs 23, 25, 28, 32, 36 mm BIFURCATED PROXIMAL MARKERS LIMBS PROXIMAL MARKERS LIMBS PROXIMAL MARKERS 16 mm 16 mm BIFURCATED GRAFT 103 mm 14 mm 14 mm LIMBS 82, 93, 124, 156, 199 mm LIMBS 82, 93, 124, 156, 199 mm 10, 13, 16, 20, 24, 28 mm DISTINCT RADIOPAQUE MARKERS Radiopaque markers e-shaped proximal markers Internal ring marker only seen under fluoroscopy 10, 13, 16, 20, 24, 28 mm * Reference product codes for available size combinations. The 3-5 stent overlap is available only with select limbs. Please refer to the Instructions for Use for more information. 11
14 Endurant II / IIs AAA Stent System COMPONENT PLACEMENT GUIDE The only device with an FDA-approved AUI Indication * 23, 25, 28, 32, 36 mm AUI PROXIMAL MARKERS LIMBS PROXIMAL MARKERS 16 mm AUI GRAFT 102 mm ALIGN MARKERS 14 mm LIMBS 82, 93, 124, 156, 199 mm 10, 13, 16, 20, 24, 28 mm 12
15 AORTIC EXTENSION PROXIMAL MARKERS ILIAC EXTENSION PROXIMAL MARKERS 23, 25, 28, 32, 36 mm 10, 13, 20, 24, 28 mm ILIAC EXTENSION 82 mm AORTIC EXTENSION 49, 70 mm 23, 25, 28, 32, 36 mm 10, 13, 20, 24, 28 mm DISTINCT RADIOPAQUE MARKERS Radiopaque markers e-shaped proximal markers * As of April The limb mates with the AUI stent graft on the ipsilateral side. Requires minimum 3 stent overlap. See Instructions for Use for more information. 13
16 Endurant II / IIs AAA Stent System 23, 25, 28, 32, 36 mm PROXIMAL DIAMETERS B C TOTAL COVERED LENGTH D A 13, 16 mm ENDURANT II BIFURCATIONS STRAIGHT LIMBS 14
17 ENDURANT II BIFURCATIONS STRAIGHT LIMBS Proximal Product Code Design Total Covered Length Delivery System Dimensions A B C D ETBF C 124 E ETBF C 145 E ETBF C 166 E ETBF C 124 E ETBF C 145 E ETBF C 166 E ETBF C 124 E ETBF C 145 E ETBF C 166 E ETBF C 124 E ETBF C 145 E ETBF C 166 E ETBF C 124 E ETBF C 145 E ETBF C 166 E ETBF C 124 E ETBF C 145 E ETBF C 166 E ETBF C 145 E ETBF C 166 E
18 Endurant II / IIs AAA Stent System 23, 28, 32, 36 mm PROXIMAL DIAMETERS B TOTAL COVERED LENGTH D E A C F 16, 20 mm ENDURANT II BIFURCATIONS-FLARED LIMBS 16
19 ENDURANT II BIFURCATIONS FLARED LIMBS Product Code Proximal Design Total Covered Delivery Length System Dimensions A B C D E F ETBF C 124 E ETBF C 145 E ETBF C 166 E ETBF C 124 E ETBF C 145 E ETBF C 166 E ETBF C 124 E ETBF C 145 E ETBF C 166 E ETBF C 145 E ETBF C 166 E
20 Endurant II / IIs AAA Stent System 23, 25, 28, 32, 36 mm PROXIMAL DIAMETERS TOTAL COVERED LENGTH D B C A 14 mm ENDURANT IIs BIFURCATIONS 18
21 ENDURANT IIs BIFURCATIONS Proximal Product Code Design Total Covered Delivery Length System Dimensions A B C D ESBF C 103 E ESBF C 103 E ESBF C 103 E ESBF C 103 E ESBF C 103 E
22 Endurant II / IIs AAA Stent System TAPERED LIMBS Proximal Product Code Design Total Covered Length Delivery System Dimensions A B ETLW C 82 E ETLW C 93 E ETLW C 124 E ETLW C 156 E ETLW C 199 E ETLW C 82 E ETLW C 93 E ETLW C 124 E ETLW C 156 E ETLW C 199 E mm PROXIMAL DIAMETER TOTAL COVERED LENGTH A B 10, 13 mm 20 TAPERED LIMBS
23 STRAIGHT LIMBS Proximal Product Code Design Total Covered Length Delivery System ETLW C 82 E ETLW C 93 E ETLW C 124 E ETLW C 156 E ETLW C 199 E 16 mm PROXIMAL DIAMETER TOTAL COVERED LENGTH 16 mm STRAIGHT LIMBS 21
24 Endurant II / IIs AAA Stent System 16 mm PROXIMAL DIAMETER TOTAL COVERED LENGTH A B 20, 24, 28 mm FLARED LIMBS 22
25 FLARED LIMBS Proximal Product Code Design Total Covered Length Delivery System Dimensions A B ETLW C 82 E ETLW C 93 E ETLW C 124 E ETLW C 156 E ETLW C 199 E ETLW C 82 E ETLW C 93 E ETLW C 124 E ETLW C 156 E ETLW C 199 E ETLW C 82 E ETLW C 93 E ETLW C 124 E ETLW C 156 E ETLW C 199 E
26 Endurant II / IIs AAA Stent System ILIAC EXTENSIONS Proximal Product Code Design Total Covered Length Delivery System ETEW C 82 E ETEW C 82 E ETEW C 82 E ETEW C 82 E ETEW C 82 E 10, 13, 20, 24, 28 mm PROXIMAL DIAMETERS TOTAL COVERED LENGTH 10, 13, 20, 24, 28 mm ILIAC EXTENSIONS 24
27 AUI Proximal Product Code Design Total Covered Length Delivery System Dimensions ETUF C 102 E ETUF C 102 E ETUF C 102 E ETUF C 102 E ETUF C 102 E A B 23, 25, 28, 32, 36 mm PROXIMAL DIAMETERS TOTAL COVERED LENGTH A B 14 mm AUI 25
28 Endurant II / IIs AAA Stent System 23, 25, 28, 32, 36 mm PROXIMAL DIAMETERS TOTAL COVERED LENGTH 23, 25, 28, 32, 36 mm AORTIC EXTENSIONS 26
29 AORTIC EXTENSIONS Proximal Product Code Design Total Covered Length Delivery System ETCF C 49 E ETCF C 49 E ETCF C 49 E ETCF C 49 E ETCF C 49 E ETTF C 70 E ETTF C 70 E ETTF C 70 E ETTF C 70 E ETTF C 70 E 27
30 Talent Occluder with Occluder Delivery System FEATURES Double spring configuration securely anchors in the iliac artery to seal the lumen and to prevent retrograde blood flow. COMPONENT PLACEMENT GUIDE PRODUCT CODE DESCRIPTION OCL 8 US Catheter Total Length Proximal / Device Configuration OCL - Occluder TALENT OCCLUDER mm 8 24 mm Radiopaque markers 28
31 OCCLUDER TALENT OCCLUDER Product Code Proximal Total Length Catheter (F) OCL 8 US OCL 10 US OCL 12 US OCL 14 US OCL 16 US OCL 18 US OCL 20 US OCL 22 US OCL 24 US
32 Valiant Thoracic Stent Captivia Delivery System FEATURES Conformability Delivered Sinusoidal shape and placement of nitinol springs provide flexibility and conformability Super-elastic nitinol springs exert active radial force to enhance seal and conformability Settle for Nothing Less Tip capture provides controlled deployment and precise placement in the thoracic aorta Tip capture release handle provides simple turn-and-pull motion to release proximal stents Advanced Design * Proximal 8-Peak FreeFlo configuration evenly distributes radial force over multiple apices Platinum iridium Figur8 markers provide high visibility and assist deployment Broad selection of proximal and distal components treats a variety of patients Optimized Access Hydrophilic coating facilitates stent graft delivery Easy three-step deployment process * Test data on file at Medtronic. Bench test results may not be indicative of clinical performance. 30
33 COMPONENT PLACEMENT GUIDE mm mm FREEFLO STRAIGHT (PROXIMAL COMPONENT) mm mm FREEFLO TAPERED (PROXIMAL COMPONENT) mm mm ~12 mm 8-Peak CLOSED WEB STRAIGHT (DISTAL COMPONENT) mm mm mm mm CLOSED WEB STRAIGHT (DISTAL COMPONENT) mm mm DISTAL BARE SPRING STRAIGHT (DISTAL COMPONENT) mm mm mm 8 0 VALIANT CAPTIVIA ~12 mm 8-Peak DISTINCT RADIOPAQUE MARKERS 8 Figur8 marker 0 Zer0 marker 31
34 Valiant Thoracic Stent Captivia Delivery System Medtronic recommends that the Valiant thoracic stent graft with the Captivia delivery system be used according to the sizing guidelines contained in the IFU. Proper sizing of the Valiant thoracic stent graft is the responsibility of the physician. Aneurysms, Penetrating Ulcers and Traumatic Ruptures: Full sizing guidelines are detailed in the instructions for use (IFU). Additional oversizing should not be incorporated. Please visit manuals.medtronic. com for more detailed sizing information. FUSIFORM & SACCULAR ANEURYSMS AND PENETRATING ULCERS SIZING GUIDELINES Native Vessel Suggested FreeFlo Straight Stent 18, , , , , 26, , 28, , 30, , , , , , , Dissection: For Dissections, appropriate oversizing has already been incorporated into the recommended sizes. Additional oversizing should not be incorporated. Oversizing of the stent graft to the vessel >10% may be unsafe in the presence of dissecting tissue or intramural hematoma. For Additional Sections: When multiple stent grafts are needed to exclude the target lesion, and the component junction or overlapping connection is not supported by the aorta, the diameter of the inside component should be oversized by 4 mm relative to the outside component. If it is supported by the vessel, oversizing to the supporting native vessel should be used. 32
35 BLUNT TRAUMATIC AORTIC INJURY SIZING GUIDELINES Native Vessel Suggested Stent DISSECTION SIZING GUIDELINES Native Vessel Suggested Stent
36 Valiant Thoracic Stent Captivia Delivery System VALIANT CAPTIVIA PRODUCT CODE DESCRIPTION VA M F C 100 TU Delivery System TU - Thoracic Stent Covered Length Catheter Outer Nominal Stent Covered Length Design C - Closed Web 1 B - Bare Spring mm Proximal Proximal Design C - Closed Web 1 F - FreeFlo Device Configuration M - Main Stent Product Name VA - Valiant TOTAL COVERED LENGTH mm mm 1. Proximal end of closed web also includes a mini support spring, while the distal end does not have a mini support spring. PROXIMAL FREEFLO STRAIGHT 34
37 PROXIMAL FREEFLO STRAIGHT Proximal Product Code Design Catheter Outer (F) Stent Covered Length VAMF C 100 TU VAMF C 100 TU VAMF C 100 TU VAMF C 100 TU VAMF C 100 TU VAMF C 100 TU VAMF C 100 TU VAMF C 100 TU VAMF C 100 TU VAMF C 100 TU VAMF C 100 TU VAMF C 100 TU VAMF C 100 TU VAMF C 150 TU VAMF C 150 TU VAMF C 150 TU VAMF C 150 TU VAMF C 150 TU VAMF C 150 TU VAMF C 150 TU VAMF C 150 TU VAMF C 150 TU VAMF C 150 TU VAMF C 150 TU VAMF C 150 TU VAMF C 150 TU VAMF C 200 TU VAMF C 200 TU VAMF C 200 TU VAMF C 200 TU VAMF C 200 TU VAMF C 200 TU VAMF C 200 TU VAMF C 200 TU VAMF C 200 TU
38 Valiant Thoracic Stent Captivia Delivery System mm TOTAL COVERED LENGTH mm mm PROXIMAL FREEFLO TAPERED 36
39 PROXIMAL FREEFLO TAPERED Product Code Proximal Design Nominal Stent Covered Length Delivery System Catheter Outer (F) Stent Covered Length VAMF C 150 TU VAMF C 150 TU VAMF C 150 TU VAMF C 150 TU VAMF C 150 TU VAMF C 150 TU VAMF C 150 TU VAMF C 150 TU VAMF C 150 TU VAMF C 150 TU VAMF C 150 TU
40 Valiant Thoracic Stent Captivia Delivery System mm TOTAL COVERED LENGTH mm mm CLOSED WEB STRAIGHT 38
41 CLOSED WEB STRAIGHT Proximal Product Code Design Catheter Outer (F) Stent Covered Length VAMC C 100 TU VAMC C 100 TU VAMC C 100 TU VAMC C 100 TU VAMC C 100 TU VAMC C 100 TU VAMC C 100 TU VAMC C 100 TU VAMC C 100 TU VAMC C 100 TU VAMC C 100 TU VAMC C 100 TU VAMC C 100 TU VAMC C 150 TU VAMC C 150 TU VAMC C 150 TU VAMC C 150 TU VAMC C 150 TU VAMC C 150 TU VAMC C 150 TU VAMC C 150 TU VAMC C 150 TU VAMC C 150 TU VAMC C 150 TU VAMC C 150 TU VAMC C 150 TU VAMC C 200 TU VAMC C 200 TU VAMC C 200 TU VAMC C 200 TU VAMC C 200 TU VAMC C 200 TU VAMC C 200 TU VAMC C 200 TU VAMC C 200 TU
42 Valiant Thoracic Stent Captivia Delivery System mm TOTAL COVERED LENGTH mm mm CLOSED WEB TAPERED 40
43 CLOSED WEB TAPERED Product Code Proximal Design Nominal Stent Covered Length Delivery System Catheter Outer (F) Stent Covered Length VAMC C 150 TU VAMC C 150 TU VAMC C 150 TU VAMC C 150 TU VAMC C 150 TU VAMC C 150 TU VAMC C 150 TU VAMC C 150 TU VAMC C 150 TU VAMC C 150 TU VAMC C 150 TU
44 Valiant Thoracic Stent Captivia Delivery System mm TOTAL COVERED LENGTH mm mm DISTAL BARE SPRING STRAIGHT 42
45 DISTAL BARE SPRING STRAIGHT Proximal Product Code Design Nominal Stent Covered Length (mm Delivery System Catheter Outer (F) Stent Covered Length VAMC B 100 TU VAMC B 100 TU VAMC B 100 TU VAMC B 100 TU VAMC B 100 TU VAMC B 100 TU VAMC B 100 TU VAMC B 100 TU VAMC B 100 TU VAMC B 100 TU VAMC B 100 TU VAMC B 100 TU VAMC B 100 TU
46 Aptus Heli-FX EndoAnchor System FEATURES Enhance outcomes and durability Designed to bring the stability of a surgical anastomosis to endovascular aneurysm repair Enhances the inherent sealing and fixation mechanisms of an endograft Simplifies revision surgery for endograft migration and Type I endoleak Tailor seal and fixation in primary and revision EVAR and TEVAR Steerable guide for precise and accurate EndoAnchor implant placement Motorized, intuitive controls for precise placement of EndoAnchors Allow safe and effective treatment of more complex anatomies Maximize outcomes in complex cases Confidently and rapidly target and seal type I endoleaks Ancillary EndoAnchor Cassette addresses needs of complex EVAR and TEVAR EVAR ORDERING INFORMATION AAA Components Deflected Tip Reach Recommended Neck Working Length (cm) OD (F) Catalog Number Heli-FX Guide, SG-64 Heli-FX Guide, HG Heli-FX Applier and EndoAnchor Cassette (w/10 EndoAnchors) Ancillary EndoAnchor Cassette (w/5 EndoAnchors) NA NA SA-85 NA NA NA NA EC-05 44
47 HELI-FX GUIDE HELI-FX APPLIER ENDOANCHOR CASSETTE TIP DEFLECTION LENGTH APTUS TEVAR ORDERING INFORMATION TAA Components Deflected Tip Reach Recommended Neck Working Length (cm) OD (F) Catalog Number Heli-FX Guide, HG Heli-FX Guide, HG Heli-FX Guide, HG Heli-FX Applier and EndoAnchor Cassette (w/10 EndoAnchors) Ancillary EndoAnchor Cassette (w/5 EndoAnchors) NA NA 114cm 12 HA NA NA NA NA EC-05 45
48 TourGuide Steerable Sheath FEATURES PRECISELY GUIDE YOUR NEXT INTERVENTION * Quickly Access Indicated Anatomy with the TourGuide Steerable Sheath. * Dilator & Tip * Facilitates sheath trackability, enabling the TourGuide to advance through indicated anatomy. * Advanced Catheter Technology Provides the strength and conformability needed to pass through various interventional devices. Curve Retention * Maintains desired deflection angle, providing a stable platform for delivering devices to its desired destination. Radiopaque Tip * Provides excellent visualization during positioning, enabling accurate vessel access and potentially less manipulation. Hemostatic Seal and Flush Port Maintains hemostasis and allows for manual fluid injection. 180 Tip Deflection * Physician-directed to deliver products to a wide variety of vessel take offs, delivering diagnostic and therapeutic devices to difficult anatomic areas. 46 * Bench Test Data on file at Medtronic. Test data not indicative of clinical performance.
49 Adjustable Tip Deflection * May reduce overall procedure time by minimizing multiple exchanges associated with different catheter selections. 9 mm 17 mm 22 mm Two Working Lengths Designed to access indicated areas to perform interventions. Inner Compatibility For use with interventional devices. 45 cm 55 cm 6.5 F 7 F 8.5 F Dilator With French size and guidewire indicator. ORDERING INFORMATION Catalog Number Inner Size (F) Usable Working Length (cm) Deflection 180 TG TG TG TG TG TG TG TG TG TG TG TG
50 Sentrant Introducer Sheath with Hydrophilic Coating ENSURE SEAL Superior Hemostasis * Optimal seal versus other available sheaths Enhanced Trackability Hydrophilic coating and optimum flexibility for easier tracking through tortuous calcified iliacs Procedural Confidence Reinforced coil for kink resistance Radiopaque marker band for easy visibility Dilator locking mechanism secures desired position SUPERIOR LEAK RESISTANCE VERSUS COOK CHECK-FLO PERFORMER AND GORE DRYSEAL P-value< ml/hr Leak resistance with 0.035"/0.89mm guidewire inserted ml/hr P-value< ml/hr 25 ml/hr 17 ml/hr Lower Is Better 10 0 ml/hr 0 Medtronic Sentrant 12 F Cook Medical Check-Flo Performer Gore Medical DrySeal 0 ml/hr Medtronic Sentrant 18 F Cook Medical Check-Flo Performer Gore Medical DrySeal * Bench Test Data on file at Medtronic. Test data not indicative of clinical performance. Bench Test compared Cook Check-Flo Performer and Gore DrySeal 12 F and 18 F to Sentrant 12 F and 18 F. Medtronic Sheath had zero leakage on 0.035"/0.89 mm guidewire. 48
51 THE CHOICE FOR SUPERIOR HEMOSTASIS* RADIOPAQUE MARKER BAND REINFORCED COILED TUBING HYDROPHILIC COATING WORKING LENGTH: 28 cm GUIDEWIRE DIAMETER: 0.035"/0.89 mm LOCKING MECHANISM ON DILATOR HANDLE PRODUCT ORDERING INFORMATION Model Number Size (F) Working Length (cm) SENSH1228W SENSH1428W SENSH1628W SENSH1828W SENTRANT SENSH2028W SENSH2228W SENSH2428W SENSH2628W
52 Reliant Stent Balloon Catheter FEATURES Expand Possibilities A single-solution balloon catheter for your stent graft procedure needs Clinical uses include: Abdominal and thoracic use Endograft modeling Endoleak sealing support Widest Range of Balloon Inflation s BALLOON INFLATION TABLE 46 mm Balloon Ml (cc) * 60 CAUTION: This table is only a guide. Balloon expansion should be carefully monitored under fluoroscopy. Do not exceed maximum inflation diameter (46 mm). Rupture of balloon may occur. PRODUCT INFORMATION RELIANT STENT GRAFT BALLOON CATHETER Product Code Inflation Shaft Size (F) Usable Length (cm) Sheath Compatibility (F) REL Please reference appropriate product Instructions for Use for a more detailed list of indications, warnings, precautions and potential adverse events. * Maximum inflation diameter. Does not contain latex. 50
53 MULTIPLE PURPOSES, SINGLE SOLUTION INTRODUCER SHEATH: COMPATIBLE WITH 12 F MATERIAL TYPE: COMPLIANT POLYURETHANE (NON-LATEX) INFLATION DIAMETER: mm SHAFT SIZE: 8 F USABLE LENGTH: 100 cm GUIDEWIRE DIAMETER: 0.038" / mm OR SMALLER RELIANT 51
54 52 Endurant II / IIs AAA Stent System Indications The Endurant II/Endurant IIs bifurcated stent graft is indicated for the endovascular treatment of infrarenal abdominal aortic or aorto-iliac aneurysms. The Endurant II aorto-uniiliac (AUI) stent graft is indicated for the endovascular treatment of infrarenal abdominal aortic or aortoiliac aneurysms in patients whose anatomy does not allow the use of a bifurcated stent graft. The Endurant II/Endurant IIs stent graft system is indicated for use in patients with the following characteristics: Adequate iliac/femoral access that is compatible with vascular access techniques, devices and/or accessories Proximal neck length of 10 mm Infrarenal neck angulation of 60 Aortic neck diameters with a range of 19 to 32 mm fixation length(s) of 15 mm Iliac diameters with a range of 8 to 25 mm Morphology suitable for aneurysm repair Contraindications The Endurant II/Endurant IIs Stent System is contraindicated in: Patients who have a condition that threatens to infect the graft. Patients with known sensitivities or allergies to the device materials. Warnings and Precautions The long-term safety and effectiveness of the Endurant II/Endurant IIs Stent System has not been established. All patients should be advised that endovascular treatment requires lifelong, regular follow-up to assess the health and the performance of the implanted endovascular stent graft. Patients with specific clinical findings (e.g., endoleaks, enlarging aneurysms or changes in the structure or position of the endovascular graft) should receive enhanced follow-up. Specific follow-up guidelines are described in the Instructions for Use. Patients experiencing reduced blood flow through the graft limb, aneurysm expansion, and persistent endoleaks may be required to undergo secondary interventions or surgical procedures. The Endurant II/Endurant IIs Stent System is not recommended in patients unable to undergo or who will not be compliant with the necessary preoperative and postoperative imaging and implantation studies as described in the Instructions for Use. Renal complications may occur: 1) From an excess use of contrast agents. 2) As a result of emboli or a misplaced stent graft. The radiopaque marker along the edge of the stent graft should be aligned immediately below the lower-most renal arterial origin. Studies indicate that the danger of micro-embolization increases with increased duration of the procedure. The safety and effectiveness of the Endurant II/Endurant IIs Stent System has not been evaluated in some patient populations. Please refer to the product Instructions for Use for details. MRI Safety and Compatibility: Nonclinical testing has demonstrated that the Endurant II/Endurant IIs Stent is MR Conditional. It can be scanned safely in both 1.5T & 3.0T MR systems under certain conditions as described in the product Instructions for Use. For additional information regarding MRI please refer to the product Instructions for Use. Adverse Events Potential adverse events include (arranged in alphabetical order): amputation; anesthetic complications and subsequent attendant problems (e.g., aspiration), aneurysm enlargement; aneurysm rupture and death; aortic damage, including perforation, dissection, bleeding, rupture and death; arterial or venous thrombosis and/or pseudoaneurysm; arteriovenous fistula; bleeding, hematoma or coagulopathy; bowel complications (e.g., ileus, transient ischemia, infarction, necrosis); cardiac complications and subsequent attendant problems (e.g., arrhythmia, myocardial infarction, congestive heart failure, hypotension, hypertension); claudication (e.g., buttock, lower limb); death; edema; embolization (micro and macro) with transient or permanent ischemia or infarction; endoleak; fever and localized inflammation; genitourinary complications and subsequent attendant problems (e.g., ischemia, erosion, femoral-femoral artery thrombosis, fistula, incontinence, hematuria, infection); hepatic failure; impotence; infection of the aneurysm, device access site, including abscess formation, transient fever and pain; lymphatic complications and subsequent attendant problems (e.g., lymph fistula); neurologic local or systemic complications and subsequent attendant problems (e.g., confusion, stroke, transient ischemic attack, paraplegia, paraparesis, paralysis); occlusion of device or native
55 vessel; pulmonary complications and subsequent attendant problems; renal complications and subsequent attendant problems (e.g., artery occlusion, contrast toxicity, insufficiency, failure); stent graft: improper component placement; incomplete component deployment; component migration; suture break; occlusion; infection; stent fracture; graft twisting and/or kinking; insertion and removal difficulties; graft material wear; dilatation; erosion; puncture and perigraft flow; surgical conversion to open repair; vascular access site complications, including infection, pain, hematoma, pseudoaneurysm, arteriovenous fistula, dissection; vascular spasm or vascular trauma (e.g., iliofemoral vessel dissection, bleeding, rupture, death); vessel damage; wound complications and subsequent attendant problems (e.g., dehiscence, infection, hematoma, seroma, cellulitis) Please reference product Instructions for Use for more information regarding indications, warnings, precautions, contraindications and adverse events. CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician. Talent Occluder with Occluder Delivery System Indications The Talent Occluder with Occluder Delivery system is intended for endoluminal occlusion of the common iliac artery in order to prevent retrograde blood into the aneurysm sac when used in conjunction with a fem-fem bypass (for example, the Talent Occluder can be used in combination with the Talent Converter Stent ). The anatomical considerations are as follows: Iliac/femoral access vessel morphology that is compatible with vascular access techniques and a delivery system profile of 17.5 French Common iliac vessel diameters between 6 mm and 20 mm Contraindications The Talent Occluder is contraindicated in: Patients who have a condition that threatens to infect the graft Patients with sensitivities or allergies to the device materials Warnings and Precautions The long-term performance of the Talent Occluder has not yet been established. All patients receiving the Talent Occluder should receive enhanced follow-up. Specific followup guidelines are described in the Instructions for Use. Renal complications may occur: 1) From an excess use of contrast agents 2) As a result of emboli. Studies indicate that the danger of micro-embolization increases with increased duration of the procedure. The safety and effectiveness of the Talent Occluder System has not been evaluated in some patient populations. Please refer to the product Instructions for Use for details. MRI Safety and Compatibility: Nonclinical testing has demonstrated that the Talent Occluder is MR Conditional. It can be scanned safely in both 1.5T & 3.0T MR systems under certain conditions as described in the product Instructions for Use. For additional information regarding MRI please refer to the product Instructions for Use. Potential Adverse Events Potential adverse events include (not arranged in any particular order): Aneurysm enlargement; aneurysm rupture and death; aortic damage (including perforation, dissection, bleeding, rupture and death); arterial or venous thrombosis and/or pseudoaneurysm; bleeding, hematoma or coagulopathy; cardiac complications and subsequent attendant problems; claudication; dislodgement of preexisting graft (for example, a Talent Converter); death; embolization (micro and macro) with transient or permanent ischemia or infarction; endoleak; fever and localized inflammation; pulmonary/ respiratory complications; renal complications; surgical conversion to open repair; vascular access site complications ;vascular spasm or vascular trauma; vessel damage; wound complications and subsequent attendant problems; stent graft complications: improper component placement, incomplete component deployment, component migration, suture break, occlusion, infection, stent fracture, graft twisting and/or kinking, insertion and removal difficulties, graft material wear, dilatation, erosion, puncture, and perigraft flow. Please reference product Instructions for Use for more information regarding indications, warnings, precautions, contraindications and adverse events. CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician. 53
56 Valiant Captivia Thoracic Stent Delivery System Indications The Valiant Thoracic Stent with the Captivia Delivery System is intended for the endovascular repair of all lesions of the descending thoracic aorta (DTA) in patients having appropriate anatomy, including: iliac/femoral access vessel morphology that is compatible with vascular access techniques, devices, and/or accessories; nonaneurysmal aortic diameter in the range of 18 mm to 42mm (fusiform and saccular aneurysms/penetrating ulcers), 18 mm to 44 mm (blunt traumatic aortic injuries), or 20 mm to 44 mm (dissections); and nonaneurysmal aortic proximal and distal neck lengths 20mm (fusiform and saccular aneurysms/penetrating ulcers), landing zone 20 mm proximal to the primary entry tear (blunt traumatic aortic injuries, dissections). The proximal extent of the landing zone must not be dissected. Contraindications The Valiant Thoracic Stent with the Captivia Delivery System is contraindicated in: Patients who have a condition that threatens to infect the graft. Patients with known sensitivities or allergies to the device materials. Warnings and Precautions The long-term safety and effectiveness of the Valiant Thoracic Stent with the Captivia Delivery System has not been established. All patients should be advised that endovascular treatment requires lifelong, regular follow-up to assess the integrity and performance of the implanted endovascular stent graft. Patients with specific clinical findings (for example, enlarging aneurysm, endoleaks, migration, inadequate seal zone, or continued flow into the false lumen in the case of a dissection) should receive enhanced follow-up. Specific follow-up guidelines are described in the Instructions for Use. The Valiant Thoracic Stent with the Captivia Delivery System is not recommended in patients who cannot undergo, or who will not be compliant with, the necessary preoperative and postoperative imaging and implantation procedures as described in the Instructions for Use. Strict adherence to the Valiant Thoracic Stent sizing guidelines as described in the Instructions for Use is expected when selecting the device size. Sizing outside of this range can potentially result in endoleak, fracture, migration, infolding, or graft wear. As cautioned in the Instructions for Use, a balloon should never be used when treating a dissection. The safety and effectiveness of the Valiant Thoracic Stent with the Captivia Delivery System has not been evaluated in some patient populations. Please refer to the product Instructions for Use for details. MRI Safety and Compatibility Non-clinical testing has demonstrated that the Valiant Thoracic Stent is MR Conditional. It can be scanned safely in both 1.5T and 3.0T MR systems under specific conditions as described in the product Instructions for Use. For additional information regarding MRI please refer to the product Instructions for Use. Adverse Events Potential adverse events include, but are not limited to access failure, access site complications (e.g. spasm, trauma, bleeding, rupture, dissection), adynamic ileus, allergic reaction (to contrast, antiplatelet therapy, stent graft material), amputation, anaesthetic complications, aortic expansion (e.g. aneurysm, false lumen), aneurysm rupture, angina, arrhythmia, arterial stenosis, atelectasis, blindness, bowel ischemia/infarction, bowel necrosis, bowel obstruction, branch vessel occlusion, buttock claudication, cardiac tamponade, catheter breakage, cerebrovascular accident (CVA) / stroke, change in mental status, coagulopathy, congestive heart failure, contrast toxicity, conversion to surgical repair, death, deployment difficulties / failures, dissection / perforation / rupture of the aortic vessel and/or surrounding vasculature, embolism, endoleak(s), excessive or inappropriate radiation exposure, extrusion / erosion, failure to deliver stent graft, femoral neuropathy, fistula (including aortobronchial, aortoenteric, aortoesophageal, arteriovenous, and lymph), gastrointestinal bleeding /complications, genitourinary complications, hematoma, hemorrhage / bleeding, hypotension / hypertension, infection or fever, insertion or removal difficulties, intercostal pain, intramural hematoma, leg /foot edema, lymphocele, myocardial infarction, neuropathy, occlusion venous or arterial, pain / reaction at catheter insertion site, paralysis, paraparesis, paraplegia, paresthesia, perfusion of the false lumen, peripheral 54
57 ischemia, peripheral nerve injury, pneumonia, post-implant syndrome, procedural / post-procedural bleeding, prosthesis dilatation / infection / rupture / thrombosis, pseudoaneurysm, pulmonary edema, pulmonary embolism, reaction to anaesthesia, renal failure, renal insufficiency, reoperation, respiratory depression / failure, sepsis, seroma, shock, spinal neurological deficit, stent graft material failure (including breakage of metal portion of device) / migration / misplacement / occlusion / twisting / kinking, transient ischemic attack (TIA), thrombosis, tissue necrosis, vascular ischemia, vascular trauma, wound dehiscence, wound healing complications, wound infection. Please reference product Instructions for Use for more information regarding indications, warnings, precautions, contraindications and adverse events. CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician. Aptus Heli-FX EndoAnchor System Indications for Use: The Aptus Heli-FX EndoAnchor System is intended to provide fixation and sealing between endovascular aortic grafts and the native artery. The Aptus Heli-FX EndoAnchor System is indicated for use in patients whose endovascular grafts have exhibited migration or endoleak, or are at risk of such complications, in whom augmented radial fixation and/or sealing is required to regain or maintain adequate aneurysm exclusion. The EndoAnchor may be implanted at the time of the initial endograft placement, or during a secondary (i.e. repair) procedure. Contraindications: Treatment with the Aptus Heli-FX EndoAnchor System is contraindicated for use in the following circumstances: In patients with known allergies to the EndoAnchor Implant material (MP35N-LT) In conjunction with the Endologix Powerlink endograft Warnings: The long term performance of the EndoAnchor has not been established. All patients should be advised endovascular aneurysm treatment requires long-term, regular follow-up to assess the patient s health status and endograft performance, and the EndoAnchor does not reduce this requirement. The EndoAnchor implant and the Aptus Heli-FX EndoAnchor System have been evaluated via in vitro testing and determined to be compatible with the Cook Zenith, Cook Zenith TX2, Gore Excluder, Gore TAG, Medtronic AneuRx, Medtronic Endurant, Medtronic Talent, and Medtronic Valiant endografts. Use with endografts other than those listed above has not been evaluated. The performance of the EndoAnchor has not been evaluated for securing multiple endograft components to one another. Without EndoAnchor securement into aortic tissue, this could result in graft fabric damage, component separation, and resultant Type III endoleaks. The performance of the EndoAnchor has not been evaluated in vessels other than the aorta. Use of the EndoAnchor to secure endografts to other vessels may result in adverse patient consequences such as vascular perforation, bleeding, or damage to adjacent structures. The Aptus EndoAnchor has not been evaluated for securing multiple anatomical structures together. Such use could result in adverse patient consequences such as vascular perforation, bleeding, or embolic events. MRI Safety and Compatibility: The EndoAnchors have been determined to be MR Conditional at 3T or less when the scanner is in Normal Operating Mode with whole body averaged SAR of 2 W/kg, or in First Level Controlled Mode with a maximum whole body averaged SAR of 4 W/kg. Please refer to documentation provided by the endograft system manufacturer for MR safety status of the endograft system with which the EndoAnchors are being used. Potential Adverse Events: Possible adverse events associated with the use of Aptus Heli-FX EndoAnchor include, but are not limited to: Aneurysm rupture Death EndoAnchor embolization Endoleaks (Type III) Enteric fistula Failure to correct/prevent Type I endoleak Failure to prevent endograft migration Infection 55
58 Renal complications (renal artery occlusion/dissection or contrastinduced AKI) Stroke Surgical conversion to open repair Vascular access complications, including infection, pain, hematoma, pseudoaneurysm, arteriovenous fistula Vessel damage, including dissection, perforation, and spasm Please reference product Instructions for Use for more information regarding indications, warnings, precautions, contraindications and adverse events. CAUTION: Federal (USA) law restricts these devices to sale by or on the order of a licensed healthcare practitioner. See package inserts for full product information. CAUTION: EndoAnchor implant locations should be based upon a detailed examination of the preoperative CT imaging in cases involving irregular or eccentric plaque in the intended sealing zone(s). EndoAnchors should be implanted only into areas of aortic tissue free of calcified plaque or thrombus, or where such pathology is diffuse and less than 2mm in thickness. Attempting to place EndoAnchors into more severe plaque or thrombus may be associated with implantation difficulty and suboptimal endograft fixation and/ or sealing. TourGuide Steerable Sheath The following disclosures must be on all promotional/advertising materials. CAUTION: Federal Law restricts this device to sale by or on the order of a physician (U.S.A.). Please refer to the Instructions for Use for a complete listing of the indications, contraindications, precautions and warnings, where applicable. Important Information: Prior to use, refer to the Instructions for Use supplied with these devices for indications, contraindications, suggested procedure, warnings and precautions. Failure to properly follow the instructions for use, warnings, and precautions may lead to serious consequences or injury to the patient. If the indications for use of the device are discussed, the following statement must appear: Indications for Use: The steerable sheath, model TourGuide is intended for the introduction of diagnostic and therapeutic devices into the human vasculature, including but not limited to intracardiac, renal or other peripheral placements. Do not use this device for neural placements. Contraindications: Known active or systemic local infection Known inability to obtain vascular access Patients with atrial thrombosis or myxoma, or interatrial baffle or patch Use of a steerable sheath is contraindicated in patients with obstructive or inadequate vasculature Potential Adverse Events: Possible adverse events associated with the use of TourGuide Steerable Sheath include, but are not limited to: Air Embolism Allergic reaction to contrast media Aortic puncture Arrhythmias Arteriovenous fistula formation Atrial septal defect Bleeding plexus injury Catheter entrapment Cardiac tamponade Coronary artery spasm and/or damage Dislodgement Dissection Endocarditis Heart Block Hematoma formation Hemorrhage Hemothorax Infection Intimal tear Irregular heart beat Local nerve damage Mediastinal widening Myocardial infarction Pacemaker/defibrillator lead displacement Perforation Pericardial/pleural effusion Pneumothorax Pseudoaneurysm formation Pulmonary edema Stroke Subclavian artery puncture Thromboembolic events Thrombophlebitis Valve damage Vascular occlusion Vasovagal reaction Vessel damage/vessel trauma Vessel spasm 56
59 PRECAUTION: Transvenous device compatibility: Use the steerable sheath only with compatible transvenous devices. Use the appropriate size sheath for the size of the transvenous device being utilized. Consequences of using the steerable sheath with incompatible devices may include the inability to deliver the transvenous device or damage to the transvenous device during delivery. WARNING: If the patient has left bundle branch block, back up pacing should be readily available during insertion of the steerable sheath assembly. Use of the steerable sheath assembly may cause heart block. Sentrant Introducer Sheath with Hydrophilic Coating Important Information: Prior to use, refer to the Instructions for Use supplied with these devices for indications, contraindications, suggested procedure, warnings and precautions. Indications for Use: The Medtronic Sentrant Introducer Sheaths with Hydrophilic Coating are intended to provide a conduit for the insertion of diagnostic or endovascular devices into the vasculature and to minimize blood loss associated with such insertions. CAUTION: Federal (USA) law restricts these devices to sale by or on the order of a licensed healthcare practitioner. See package inserts for full product information. Reliant Stent Balloon Catheter Important Information: Prior to use, refer to the Instructions for Use supplied with these devices for indications, contraindications, suggested procedure, warnings and precautions. Indications for Use: The Reliant Stent Balloon Catheter is intended for temporary occlusion of large vessels or to expand vascular prostheses. CAUTION: Federal (USA) law restricts these devices to sale by or on the order of a licensed healthcare practitioner. See package inserts for full product information. 57
60 58 NOTES
61 NOTES 59
62 NOTES
63
64 Aortic Peripheral endovenous 3576 Unocal Place Santa Rosa, CA USA 24-hour Technical Support Toll free: medtronic.com/aortic Orders Toll free: Fax: CardioVascular LifeLine Customer Support Tel: Toll free: UC EN Medtronic All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. All other brands are trademarks of a Medtronic company. Printed in the USA. For distribution in the USA only. 4/16
Talent Abdominal Stent Graft
Talent Abdominal with THE Xcelerant Hydro Delivery System Expanding the Indications for EVAR Treat More Patients Short Necks The Talent Abdominal is the only FDA-approved device for proximal aortic neck
More informationFROM THE EVERYDAY TO THE EXTRAORDINARY
FROM THE EVERYDAY TO THE EXTRAORDINARY Created with the collaboration of more than 250 physicians around the world, ENDURANT empowers you to create stronger outcomes for more patients, including those
More informationInnovating for life. CardioVascular LifeLine Customer Support Tel: Tel:
Indications The Valiant Thoracic with the Captivia Delivery System is intended for the endovascular repair of fusiform aneurysms and saccular aneurysms/penetrating ulcers of the descending thoracic aorta
More informationAccess More Patients. Customize Each Seal.
Access More. Customize Each Seal. The Least Invasive Path Towards Proven Patency ULTRA LOW PROFILE TO EASE ADVANCEMENT The flexible, ultra-low 12F ID Ovation ix delivery system enables you to navigate
More informationBifurcated system Proximal suprarenal stent Modular (aortic main body and two iliac legs) Full thickness woven polyester graft material Fully
Physician Training Bifurcated system Proximal suprarenal stent Modular (aortic main body and two iliac legs) Full thickness woven polyester graft material Fully supported by self-expanding z-stents H&L-B
More informationZenith Renu AAA Converter Graft. Device Description Planning and Sizing Deployment Sequence Patient Follow-Up
Zenith Renu AAA Converter Graft Device Description Planning and Sizing Deployment Sequence Patient Follow-Up Device description: Device indications The Zenith Renu AAA Converter Graft with Z-Trak Introduction
More informationIndications for use. Contraindications within the United States
Indications for use Indications within the United States The GORE TAG Thoracic Endoprosthesis is intended for endovascular repair of all lesions of the descending thoracic aorta, including: Isolated lesions
More informationTHE THE MORE MORE NATURAL APPROACH TO OPTIMAL FIT
THE THE MORE MORE NATURAL APPROACH Natural Approach TO Optimal Fit TO OPTIMAL FIT Conformability without Compromise THE STANDARD IN Conformability AND Designed for flexibility and conformability in tortuous
More informationMy personal experience with INCRAFT in standard and challenging cases
My personal experience with INCRAFT in standard and challenging cases G Pratesi, MD Vascular Surgery University of Rome Tor Vergata giovanni.pratesi@uniroma2.it Disclosure Speaker name: Giovanni Pratesi,
More informationGORE EXCLUDER AAA Endoprosthesis ANNUAL CLINICAL UPDATE OCTOBER Section I Clinical experience. Section II Worldwide commercial experience
GORE EXCLUDER AAA Endoprosthesis ANNUAL CLINICAL UPDATE OCTOBER 2018 Abstract This annual clinical update provides a review of the ongoing experience with the GORE EXCLUDER AAA Endoprosthesis used in the
More informationCook Medical. Zenith Flex AAA Endovascular Graft with Z-Trak Introduction System Physician Training
Cook Medical Zenith Flex AAA Endovascular Graft with Z-Trak Introduction System Physician Training Bifurcated system Proximal suprarenal stent Modular (aortic main body and two iliac legs) Full-thickness,
More informationDEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
M AY. 6. 2011 10:37 A M F D A - C D R H - O D E - P M O N O. 4147 P. 1 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control
More informationAortic stents, types, selection, tricks in deployment.
Aortic stents, types, selection, tricks in deployment. Hamdy Soliman.M.D,FSCAI Consultant of Cardiology&Head of Endovascular Unit National Heart Institute Endovascular Treatment of Thoracic Aortic Aneurysms
More informationTriVascular Ovation Prime Abdominal Stent Graft System
TriVascular Ovation Prime Abdominal Stent Graft System Science of the Seal O-Ring Sealing Technology O-Ring Sealing in Proven Engineering Solutions O-rings are designed to seal by blocking the flow of
More informationDurability of The Endurant Stent-Graft through 5 Years
Durability of The Endurant Stent-Graft through 5 Years Michel S. Makaroun MD Co-Director, UPMC Heart and Vascular Institute Professor and Chair, Division of Vascular Surgery University of Pittsburgh School
More informationCASE BOOK: ENDOANCHOR TM FIXATION UC EN
CASE BOOK: ENDOANCHOR TM FIXATION UC201700368 EN PURPOSE OF THIS MATERIAL The Aptus TM Heli-FX TM EndoAnchor TM systems have been used in over 5,000 patients worldwide, with over 30,000 EndoAnchor implants
More informationRobert F. Cuff, MD FACS SHMG Vascular Surgery
Robert F. Cuff, MD FACS SHMG Vascular Surgery Objectives To become familiar with the commercially available fenestrated EVAR graft Discuss techniques to increase success Review available data to determine
More informationQuick Reference Guide
Quick Reference Guide Indications for Use The AFX Endovascular AAA System is indicated for endovascular treatment in patients with AAA. The devices are indicated for patients with suitable aneurysm morphology
More informationChallenging anatomies demand versatility.
Challenging anatomies demand versatility. The Distinct Advantages of Separating Seal and Fixation ANATOMICAL FIXATION Unlike proximal fixation designs, the AFX bifurcated unibody endograft allows for natural
More informationAbdominal and thoracic aneurysm repair
Abdominal and thoracic aneurysm repair William A. Gray MD Director, Endovascular Intervention Cardiovascular Research Foundation Columbia University Medical Center Abdominal Aortic Aneurysm Endografts
More informationThe Endurant Stent Graft System
The Stent Graft System Instructions for Use (IFU) IMPORTANT! Do not attempt to use the Stent Graft System before completely reading and understanding the information contained in the Instructions for Use.
More informationAssurant Cobalt Iliac BALLOON EXPANDABLE STENT SYSTEM
Assurant Cobalt Iliac BALLOON EXPANDABLE STENT SYSTEM Innovating for life. CONFORMABILIT Y 6 F S H E AT H C O M PAT I B I L I T Y THE ASSURANT COBALT ILIAC STENT, WITH ITS UNIQUE COBALT CHROMIUM MODULAR
More informationLOWERING THE PROFILE RAISING THE BAR
LOWERING THE PROFILE RAISING THE BAR INNOVATIVE LOW PROFILE. ADVANCED CLINICAL PERFORMANCE. The AFX TM Endovascular AAA System integrates anatomical fixation with an advanced delivery system and graft
More informationDURABLE. CONSISTENT. SAFE. IN.PACT Admiral Drug-Coated Balloon
DURABLE. CONSISTENT. SAFE. Drug-Coated Balloon THE SCIENCE BEHIND THE OUTCOMES DCB has proven, long-term durable outcomes across multiple clinical trials, as well as across complex patient and lesion types.
More informationChallenges with Complex Anatomies Advancing Care in Endovascular Aortic Treatment
Challenges with Complex Anatomies Advancing Care in Endovascular Aortic Treatment Robert Y. Rhee, MD Chief, Vascular and Endovascular Surgery Director, Aortic Center Maimonides Medical Center Brooklyn,
More informationA New EVAR Device for Infrarenal AAAs
A New EVAR Device for Infrarenal AAAs Peter Nelson, MD, MS Assistant Professor of Surgery MM0203 Rev. 01 Current U.S. EVAR Devices Anatomical Fixation Proximal Fixation Powerlink - Endologix Excluder WL
More informationChallenges. 1. Sizing. 2. Proximal landing zone 3. Distal landing zone 4. Access vessels 5. Spinal cord ischemia 6. Endoleak
Disclosure I have the following potential conflicts of interest to report: Consulting: Medtronic, Gore Employment in industry Stockholder of a healthcare company Owner of a healthcare company Other(s)
More informationPercutaneous Approaches to Aortic Disease in 2018
Percutaneous Approaches to Aortic Disease in 2018 Wendy Tsang, MD, SM Assistant Professor, University of Toronto Toronto General Hospital, University Health Network Case 78 year old F Lower CP and upper
More informationThe SplitWire Percutaneous Transluminal Angioplasty Scoring Device. Instructions for Use
The SplitWire Percutaneous Transluminal Angioplasty Scoring Device Instructions for Use Contents Contains one (1) SplitWire device. Sterile. Sterilized with ethylene oxide gas. Radiopaque. For single use
More informationHistory of the Powerlink System Design and Clinical Results. Edward B. Diethrich Arizona Heart Hospital Phoenix, AZ
History of the Powerlink System Design and Clinical Results Edward B. Diethrich Arizona Heart Hospital Phoenix, AZ Powerlink System: Unibody-Bifurcated Design Long Main Body Low-Porosity Proprietary eptfe
More informationAncillary Components with Z-Trak Introduction System
Ancillary Components with Z-Trak Introduction System Zenith Flex AAA Endovascular Graft Ancillary Components Converter Converters can be used to convert a bifurcated graft into an aortouniiliac graft if
More informationAnatomical challenges in EVAR
Anatomical challenges in EVAR M.H. EL DESSOKI, MD,FRCS PROFESSOR OF VASCULAR SURGERY CAIRO UNIVERSITY Disclosure Speaker name:... I have the following potential conflicts of interest to report: Consulting
More informationZenith Alpha T HORACIC ENDOVASCULAR GRAFT
Device description Zenith Alpha T HORACIC ENDOVASCULAR GRAFT www.cookmedical.com AI-D21181-EN-F Modular design The two-piece modular system allows the physician to customize a graft system to fit each
More informationREBEL. Platinum Chromium Coronary Stent System. Patient Information Guide
REBEL Patient Information Guide REBEL PATIENT INFORMATION GUIDE You have recently had a REBEL bare metal stent implanted in the coronary arteries of your heart. The following information is important for
More informationEndovascular Repair o Abdominal. Aortic Aneurysms. Cesar E. Mendoza, M.D. Jackson Memorial Hospital Miami, Florida
Endovascular Repair o Abdominal Aortic Aneurysms Cesar E. Mendoza, M.D. Jackson Memorial Hospital Miami, Florida Disclosure Nothing to disclose. 2 Mr. X AAA Mr. X. Is a 70 year old male who presented to
More informationCP STENT. Large Diameter, Balloon Expandable Stent
CP STENT Large, Expandable CP STENT OPTIONS 12mm to Expansion 26mm to Expansion CP Matrix (number of zigs) 1.6 2.2 2.8 3.4 3.9 4.5 5 5.5 6 12 14 15 16 18 20 22 24 26 28 30 CP Details: CP is composed of
More informationEndoanchor-assisted TEVAR
Endoanchor-assisted TEVAR May 29, 2015 NCVH2015 Grayson H. Wheatley III, MD Director of Aortic and Endovascular Surgery Associate Professor of Surgery Temple University School of Medicine Disclosures Consultant
More informationENG TREO ABDOMINAL STENT-GRAFT SYSTEM TABLE OF CONTENTS
TREO ABDOMINAL STENT-GRAFT SYSTEM TABLE OF CONTENTS 1. DEVICE DESCRIPTION 28 1.1. Stent-Graft 28 1.1.1. Main Bifurcated Stent-Graft 28 1.1.2. Leg Extensions 28 1.2. Delivery System for the Bifurcated Main
More informationDurable outcomes. Proven performance.
Durable outcomes. Proven performance. GORE EXCLUDER AAA Endoprosthesis GORE EXCLUDER Iliac Branch Endoprosthesis GORE EXCLUDER AAA Endoprosthesis The most-studied* EVAR stent graft designed for durable
More informationRuby Coil. Large Volume Detachable Coils
Ruby Coil Ruby Case Examples 38 mm Hepatic Artery Aneurysm Pulmonary AVM 2 Coils Dr. James Benenati Miami Cardiac and Vascular Institute, FL Y90 Embolization Type 2 Endoleak Dr. J Moskovitz Florida Hospital,
More informationENCORE, a Study to Investigate the Durability of Polymer EVAR with Ovation A Contemporary Review of 1296 Patients
ENCORE, a Study to Investigate the Durability of Polymer EVAR with Ovation A Contemporary Review of 1296 Patients The Ovation System is approved to treat infrarenal abdominal aortic aneurysms and is not
More informationOptimizing Accuracy of Aortic Stent Grafts in Short Necks
Optimizing Accuracy of Aortic Stent Grafts in Short Necks Venkatesh Ramaiah, MD, FACS Medical Director Arizona Heart Hospital Director Peripheral Vascular and Endovascular Research Arizona Heart Institute
More informationHostile Proximal Neck: A New Conformable EVAR Device
Hostile Proximal Neck: A New Conformable EVAR Device Young-Guk Ko, M.D., Seoul, Korea Currently Available Devices for EVAR in Korea, 2018 Zenith Flex, Cook Endurant IIs, Medtronic INCRAFT, Cordis AFX2,
More informationNellix Endovascular System: Clinical Outcomes and Device Overview
Nellix Endovascular System: Clinical Outcomes and Device Overview Jeffrey P. Carpenter, MD Professor and Chief, Department of Surgery CAUTION: Investigational device. This product is under clinical investigation
More informationER REBOA Catheter. Instructions for Use
ER REBOA Catheter Instructions for Use Prytime Medical Devices, Inc. 229 N. Main Street Boerne, TX 78006, USA feedback@prytimemedical.com www.prytimemedical.com US 1 210 340 0116 U.S. and Foreign Patents
More informationTechnique and Tips for Complicated AAA Cases with Stent Graft
Technique and Tips for Complicated AAA Cases with Stent Graft Seung-Woon Rha, MD, PhD FACC, FAHA, FESC, FSCAI, FAPSIC Cardiovascular Center, Korea University Guro Hospital Mar 15, 2018 LINC AP 2018 Endoleak;
More informationDevelopment of a Branched LSA Endograft & Ascending Aorta Endograft
Development of a Branched LSA Endograft & Ascending Aorta Endograft Frank R. Arko III, MD Sanger Heart & Vascular Institute Carolinas Medical Center Charlotte, North Carolina, USA Disclosures Proximal
More informationAbdominal Aortic Aneurysm 가천대길병원 이상준
Abdominal Aortic Aneurysm 가천대길병원 이상준 1 Definition Diameter of the aorta 1.5 times greater than normal. Most are infrarenal, and a significant number extend down into one or both iliac arteries Abdominal
More informationClinical experience with a new thoracic stent graft system (Ankura TM ). Procedural analysis, 30 days and 6-month results in a single center study
Clinical experience with a new thoracic stent graft system (Ankura TM ). Procedural analysis, 30 days and 6-month results in a single center study Theodoros Kratimenos, MD Consultant, Interventional Radiologist
More informationEVAR Revision Setting - How can Heli-FX EndoAnchors improve the outcomes?
D. Böckler Department of Vascular and Endovascular Surgery University Hospital Heidelberg EVAR Revision Setting - How can Heli-FX EndoAnchors improve the outcomes? Disclosures Speaker name: Dittmar Böckler
More informationVALIANT THORACIC STENT GRAFT WITH THE CAPTIVIA DELIVERY SYSTEM 2016 ANNUAL PHYSICIAN CLINICAL UPDATE
VALIANT THORACIC STENT GRAFT WITH THE CAPTIVIA DELIVERY SYSTEM 2016 ANNUAL PHYSICIAN CLINICAL UPDATE MARCH 27, 2016 2016 ANNUAL PHYSICIAN CLINICAL UPDATE VALIANT THORACIC STENT GRAFT WITH THE CAPTIVIA
More informationThe evolution. AORFIX AAA Stent Graft now with the new AORFLEX Delivery System
The evolution of AORFIX AORFIX AAA Stent Graft now with the new AORFLEX Delivery System The confident choice for the right angles AORFIX the only AAA stent graft approved for all angulations from 0 90,
More informationCurrent Status of EVAR for Infrarenal AAA. 31 st Annual Florida Vascular Society. PENN Surgery
Current Status of EVAR for Infrarenal AAA 31 st Annual Florida Vascular Society PENN Surgery No Disclosures Stent Grafts Design Related Differences What really matters? Modular Unibody Supported Unsupported
More information1 Comparison of Warfarin and Aspirin for Symptomatic Intracranial Arterial Stenosis. N Engl J Med 352;13, March 31, 2005
The risk of ischemic stroke in patients with Intracranial Atherosclerotic Disease (ICAD) ranges from 7 to 24%. 1,2 Developed specifically for the treatment of ICAD, the Wingspan Stent System and Gateway
More informationRight Choice for Right Angles
Right Choice for Right Angles The Anatomy of Technology Aorfix gives you technology that conforms to patient anatomy, optimising both procedure and post-operative performance. Fishmouth for optimum neck
More informationHow to achieve a successful proximal sealing in TEVAR? Pr L Canaud
How to achieve a successful proximal sealing in TEVAR? Pr L Canaud CHU de Montpellier France Disclosure I have the following potential conflicts of interest to report: Consulting: Medtronic. Proximal neck
More informationHow to select FEVAR versus EVAR + endoanchors in short-necked AAAs
How to select FEVAR versus EVAR + endoanchors in short-necked AAAs Jean-Paul P.M. de Vries, Richte C.L. Schuurmann St. Antonius Hospital Nieuwegein, The Netherlands 21st Critical Issues Congress Nuernberg,
More informationSystem.
System www.penumbrainc.com POD System Case Examples 45 cm of POD Packing Coil in 1.5 to 3 mm diameter dilating vessel Bronchial Artery Embolization Dr. Amit Kakkar and Dr. Aksim Rivera, Bronx, NY Inflow:
More informationDegeneration of the Neck Post Implementation - a New Era of AAA Stent
Degeneration of the Neck Post Implementation - a New Era of AAA Stent New Mexico Heart Institute Albuquerque, New Mexico USA - Gore Current FDA-Approved EVAR Devices Sealing Mechanism Endologix Lombard
More informationAbdominal Aortic Aneurysms. A Surgeons Perspective Dr. Derek D. Muehrcke
Abdominal Aortic Aneurysms A Surgeons Perspective Dr. Derek D. Muehrcke Aneurysm Definition The abnormal enlargement or bulging of an artery caused by an injury or weakness in the blood vessel wall A localized
More informationRECOMMENDED INSTRUCTIONS FOR USE
Rapid Exchange PTCA Dilatation Catheter RECOMMENDED INSTRUCTIONS FOR USE Available in diameters 1.25mm to 4.5mm and in lengths 09mm to 40mm Caution: This device should be used only by physicians trained
More informationCurrent Status of Abdominal Aortic Stent Grafts. John R. Laird Professor of Medicine Director of the Vascular Center UC Davis Medical Center
Current Status of Abdominal Aortic Stent Grafts John R. Laird Professor of Medicine Director of the Vascular Center UC Davis Medical Center Autumn Greetings Disclosure Statement of Financial Interest Within
More informationYoung-Guk Ko, M.D. Severance Cardiovascular Hospital, Yonsei University Health System,
Young-Guk Ko, M.D., Dangas G, J Am Coll Cardiol Intv 2012;5:1071 All-cause Mortality Dangas Severance G, J Am Coll Cardiovascular Cardiol Intv Hospital, 2012;5:1071 Yonsei University Health System Aneurysm-related
More informationPatient Information Booklet
Patient Information Booklet Endovascular Stent Grafts: A Treatment for Thoracic Aortic Aneurysms Table of Contents Table of Contents Introduction 1 Anatomy of the Thoracic Aorta 2 What Is an Aneurysm?
More information1 Description. 2 Indications. 3 Warnings ASPIRATION CATHETER
Page 1 of 5 ASPIRATION CATHETER Carefully read all instructions prior to use, observe all warnings and precautions noted throughout these instructions. Failure to do so may result in complications. STERILE.
More informationInstructions for Use Reprocessed LASSO Circular Mapping Diagnostic Electrophysiology (EP) Catheter
Instructions for Use Reprocessed LASSO Circular Mapping Diagnostic Electrophysiology (EP) Catheter Caution: Federal (USA) law restricts this device to sale by or on the order of a physician. DEVICE DESCRIPTION
More informationHostile Neck During EVAR, The Role Of Endoanchores
Hostile Neck During EVAR, The Role Of Endoanchores Samer Koussayer, MD, FACS, RVT Prof, Al Faisal University Section Head and consultant Vascular & Endovascular Surgery Division King Faisal Specialist
More informationManagement of Endoleaks
Management of Endoleaks Murray Shames, MD Professor and Chief, Director Tampa General Hospital Aortic Program Vice Chair of Research, Dept. of Surgery Conflict of Interests: Speaker: Gore, Medtronic, Cook
More informationEVAR replaced standard repair in most cases. Why?
EVAR replaced standard repair in most cases. Why? Initial major steps in endograft evolution Papazoglou O. Konstantinos M.D. The story of a major breakthrough in vascular surgery 1991 Parodi introduces
More informationImproving Endograft Durability with EndoAnchors
Improving Endograft Durability with EndoAnchors William D. Jordan, Jr., M.D. John E. Skandalakis Chair in Surgery Professor and Chief Division of Vascular Surgery and Endovascular Therapy Emory University
More information2015 Clinical Update Endovascular Systems for AAA Repair
Endovascular Systems for AAA Repair 2 Musick Irvine, CA 92618 Tel 949.595.7200 Fax 949.612.1893 www.endologix.com TABLE OF CONTENTS Section Page ABSTRACT... 3 READER S GUIDE... 4 SECTION 1: US PIVOTAL
More informationSTERILE. Caution: Federal (USA) law restricts this device for sale by or on the order of a physician.
with Delivery System STERILE R Instructions for Use (IFU) Caution: Federal (USA) law restricts this device for sale by or on the order of a physician. Review the guidance in this Instructions for Use before
More informationRadRx Your Prescription for Accurate Coding & Reimbursement Copyright All Rights Reserved.
Interventional Radiology Coding Case Studies Prepared by Stacie L. Buck, RHIA, CCS-P, RCC, CIRCC, AAPC Fellow President & Senior Consultant INDICATION: Abdominal aortic aneurysm. INTERVENTIONAL RADIOLOGIST:
More informationTRAINING DOCUMENT, FOR INTERNAL USE ONLY. Pre-case Planning
TRINING DOCUMENT, FOR INTERNL USE ONLY Pre-case Planning Imaging Specifications CONTRST ENHNCED CT-SCN CT angiography date should be within 3 months of implant date CT slices thickness not exceeding 3
More informationEXPERIENCE AFTER 500 ENDOLUMINAL STENT GRAFTS. DEVICES SPECIFIC OUTCOME AND LESSONS LEARNED.
EXPERIENCE AFTER 500 ENDOLUMINAL STENT GRAFTS. DEVICES SPECIFIC OUTCOME AND LESSONS LEARNED. A/Prof. B. Patrice Mwipatayi MD, MMed (Surg), MClinEd (Melb), FCS, FRACS Department of Vascular Surgery, Royal
More informationThe Ventana Off-the-Shelf Graft for Pararenal AAA. Andrew Holden Associate Professor of Radiology Auckland Hospital
The Ventana Off-the-Shelf Graft for Pararenal AAA Andrew Holden Associate Professor of Radiology Auckland Hospital Disclosures Andrew Holden, MBChB, FRANZCR Investigator in Nellix and Ventana Trials Clinical
More informationPERFORMANCE YOU CAN TRUST. EverFlex Self-expanding Peripheral Stent with Entrust Delivery System
PERFORMANCE YOU CAN TRUST EverFlex Self-expanding Peripheral Stent with Entrust Delivery System The Entrust Delivery System is designed to provide improved patient outcomes and procedural efficiency. The
More informationIntroduction What Causes Peripheral Vascular Disease? How Do Doctors Treat Peripheral Vascular Disease?... 9
Patient Information Table of Contents Introduction... 3 What is Peripheral Vascular Disease?... 5 What Are Some of the Symptoms of Peripheral Vascular Disease?... 7 What Causes Peripheral Vascular Disease?...
More informationAcute dissections of the descending thoracic aorta (Debakey
Endovascular Treatment of Acute Descending Thoracic Aortic Dissections Nimesh D. Desai, MD, PhD, and Joseph E. Bavaria, MD Acute dissections of the descending thoracic aorta (Debakey type III or Stanford
More informationExperience of endovascular procedures on abdominal and thoracic aorta in CA region
Experience of endovascular procedures on abdominal and thoracic aorta in CA region May 14-15, 2015, Dubai Dr. Viktor Zemlyanskiy National Research Center of Emergency Care Astana, Kazakhstan Region Characteristics
More informationChungbuk Regional Cardiovascular Center, Division of Cardiology, Departments of Internal Medicine, Chungbuk National University Hospital Sangmin Kim
Endovascular Procedures for Isolated Common Iliac and Internal Iliac Aneurysm Chungbuk Regional Cardiovascular Center, Division of Cardiology, Departments of Internal Medicine, Chungbuk National University
More informationSANWICH TECHNIQUE TO REDUCE COMPLICATIONS WHEN TREATING BILATERAL INTERNAL ILIAC ARTERY
SANWICH TECHNIQUE TO REDUCE COMPLICATIONS WHEN TREATING BILATERAL INTERNAL ILIAC ARTERY TRAN TRA GIANG.MD Interventional cardiovascular department Hanoi Heart Hospital, Hanoi, Viet Nam Nothing to Disclose
More informationNON-COMPLIANT PTCA RAPID EXCHANGE DILATATION CATHETER
Page 1 of 5 NON-COMPLIANT PTCA RAPID EXCHANGE DILATATION CATHETER STERILE. SINGLE USE ONLY. Sterilized with ethylene oxide gas. Non pyrogenic. Do not resterilize. Do not use opened or damaged packages.
More information2014 ANNUAL CLINICAL UPDATE. TriVascular Inc. Ovation and Ovation Prime Abdominal Stent Graft Systems
2014 ANNUAL CLINICAL UPDATE TriVascular Inc. Ovation and Ovation Prime Abdominal Stent Graft Systems 2014 ANNUAL CLINICAL UPDATE TriVascular Inc. Ovation and Ovation Prime Abdominal Stent Graft Systems
More informationPeel-Apart Percutaneous Introducer Kits for
Bard Access Systems Peel-Apart Percutaneous Introducer Kits for Table of Contents Contents Page Bard Implanted Ports Hickman*, Leonard*, Broviac*, Tenckhoff*, and Groshong* Catheters Introduction....................................
More informationType 1a Endoleak in hostile neck anatomies: Endoanchor can fix it! D. Böckler University Hospital Heidelberg, Germany
Type 1a Endoleak in hostile neck anatomies: Endoanchor can fix it! D. Böckler University Hospital Heidelberg, Germany Disclosures Speaker name: Dittmar Böckler I have the following potential conflicts
More informationPTA Balloon Dilatation Catheter
PTA Balloon Dilatation Catheter March 2016 1/6(3214-0) Catalogue number Serial number Lot number Use by Do not reuse Do not resterilize Do not use if package is damaged Consult instructions for use Keep
More informationAXS Catalyst Distal Access Catheter
AXS Catalyst Distal Access Catheter Directions for Use 2 AXS Catalyst Distal Access Catheter ONLY Caution: Federal Law (USA) restricts this device to sale by or on the order of a physician. warning Contents
More informationObesity, Scaring, Access in EVAR. Kiskinis D, Melas N, Ktenidis K. 1 st Department of Surgery Aristotle University of Thessaloniki, Greece
Obesity, Scaring, Access in EVAR Kiskinis D, Melas N, Ktenidis K. 1 st Department of Surgery Aristotle University of Thessaloniki, Greece Obesity Decreased radiolucency (visibility) Max weight load < 160
More informationCombined Endovascular and Surgical Repair of Thoracoabdominal Aortic Pathology: Hybrid TEVAR
Combined Endovascular and Surgical Repair of Thoracoabdominal Aortic Pathology: Hybrid TEVAR William J. Quinones-Baldrich MD Professor of Surgery Director UCLA Aortic Center UCLA Medical Center Los Angeles,
More informationThe clinical update for the Zenith AAA Endovascular Graft has included results from the Zenith AAA Endovascular Graft multi-center clinical study,
The clinical update for the Zenith AAA Endovascular Graft has included results from the Zenith AAA Endovascular Graft multi-center clinical study, the 36 mm diameter Zenith Flex AAA Endovascular Graft
More informationIntroduction 3. What is Peripheral Vascular Disease? 5. What Are Some of the Symptoms of Peripheral Vascular Disease? 6
Patient Information Table of Contents Introduction 3 What is Peripheral Vascular Disease? 5 What Are Some of the Symptoms of Peripheral Vascular Disease? 6 What Causes Peripheral Vascular Disease? 7 How
More informationPerformance of the conformable GORE TAG device in Type B aortic dissection from the GORE GREAT real world registry
University of Milan Thoracic Aortic Research Center Performance of the conformable GORE TAG device in Type B aortic dissection from the GORE GREAT real world registry Santi Trimarchi, MD, PhD Associate
More informationI-Hui Wu, M.D. Ph.D. Clinical Assistant Professor Cardiovascular Surgical Department National Taiwan University Hospital
Comparisons of Aortic Remodeling and Outcomes after Endovascular Repair of Acute and Chronic Complicated Type B Aortic Dissections I-Hui Wu, M.D. Ph.D. Clinical Assistant Professor Cardiovascular Surgical
More informationINCRAFT system: Update from the Pivotal INSPIRATION Study
INCRAFT system: Update from the Pivotal INSPIRATION Study Michel S. Makaroun MD Co-Director, UPMC Heart and Vascular Institute Professor and Chair, Division of Vascular Surgery University of Pittsburgh
More informationInstructions for Use. Caution: Federal (USA) law restricts this device to sale by or on the order of a physician.
Instructions for Use Caution: Federal (USA) law restricts this device to sale by or on the order of a physician. Table of Contents 1. Device Description... 3 1.1. Delivery System... 4 1.2. Fill Polymer
More informationCOIL SYSTEM ORDERING INFORMATION
EMBOLIZATION SYSTEM RUBY COIL SYSTEM FRAME with Ruby Standard FILL with Ruby Soft Now with 3 & 40 mm sizes! SYSTEM ANCHOR with Now designed to embolize 3 4 mm vessels! PACK with Coil Now with WAVE Shape
More informationEVAR and TEVAR: Extending Their Use for Rupture and Traumatic Injury. Conflict of Interest. Hypotensive shock 5/5/2014. none
EVAR and TEVAR: Extending Their Use for Rupture and Traumatic Injury Bruce H. Gray, DO MSVM FSCAI Professor of Surgery/Vascular Medicine USC SOM-Greenville Greenville, South Carolina none Conflict of Interest
More informationBilateral use of the Gore IBE device for bilateral CIA aneurysms and a first interim analysis of the prospective Iceberg registry
Bilateral use of the Gore IBE device for bilateral CIA aneurysms and a first interim analysis of the prospective Iceberg registry Michel MPJ Reijnen, MD, PhD Department of Vascular Surgery, Rijnstate Hospital
More informationChronic Total Occlusion (CTO) Technologies
to receive our latest news and key activities. Chronic Total Occlusion (CTO) Technologies Re-open vital channels LinkedIn page Follow us on CORDIS EMEA OUTBACK LTD Re-Entry Catheter True Lumen Re-Entry
More information